Payal Soni-Patel, PA
Medical · Asheville, NCNPI 1093793192
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $59,079 of the $75,976 with a category attached, or 77.8%. AbbVie accounts for 82.4% of it on its own, with 59 other manufacturers making up the rest. Reporting peaked in 2021 at $30,491 and has fallen 77.7% since, to $6,784 in 2025. Among medical clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 833 payments — averaging $91.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$63K
- MDD US Operations, LLC$880
- UCB, Inc.$795
- Teva Pharmaceuticals USA, Inc.$593
- AstraZeneca$555
- TG Therapeutics, Inc.$435
- plus $10K from 54 others
What the payments were for
- Speaking & faculty fees$59,07978%
- Travel & lodging$1,1632%
- Food & beverage$15,68121%
- Education$530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$75,976 in reported general payments places this provider in the 95th percentile of 878 medical providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 11 | $81,252 |
| QutenzaCapsaicin/Skin Cleanser | 22 | $77,150 |
| UbrelvyUbrogepant | 31 | $46,113 |
| Emgality PenGalcanezumab-Gnlm | 60 | $42,744 |
| Aimovig AutoinjectorErenumab-Aooe | 50 | $41,516 |
| QuliptaAtogepant | 25 | $39,247 |
| Dimethyl Fumarate | 17 | $28,478 |
| RytaryCarbidopa/Levodopa | 16 | $27,825 |
| LamictalLamotrigine | 14 | $27,199 |
| Nurtec OdtRimegepant Sulfate | 20 | $24,372 |
| Lacosamide | 99 | $12,460 |
| Dalfampridine ErDalfampridine | 18 | $10,091 |
| LinzessLinaclotide | 16 | $9,874 |
| Ajovy SyringeFremanezumab-Vfrm | 13 | $9,052 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 324 | $8,525 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta, Linzess | $62,617 | $95,23472 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $343 | $81,25211 claims |
| GRT US Holding, Inc.Qutenza | $69 | $77,15022 claims |
| Amneal Pharmaceuticals LLCRytary, Pyridostigmine Bromide | $213 | $29,92840 claims |
| PfizerNurtec Odt | $208 | $24,37220 claims |
| Upsher-smith Laboratories LLCTopiramate | $90 | $1,510120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 878 medical providers in North Carolina.
Other medical in Asheville
- Frederick McIntyreAsheville$14K
- Rebecca McGowanAsheville$13K
- Grace McLaurinHickory$553K
- Joel ThompsonCharlotte$265K
- Virginia JethroCary$213K
- William JarrettElkin$59K
- Amanda ZimmermanWinston Salem$48K
- David TaylorMorehead City$40K
- Katherine CardSalisbury$39K
- John RobbinsWinston Salem$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.